CA2654010A1 - Modified microbial nucleic acid for use in detection and analysis of microorganisms - Google Patents
Modified microbial nucleic acid for use in detection and analysis of microorganisms Download PDFInfo
- Publication number
- CA2654010A1 CA2654010A1 CA002654010A CA2654010A CA2654010A1 CA 2654010 A1 CA2654010 A1 CA 2654010A1 CA 002654010 A CA002654010 A CA 002654010A CA 2654010 A CA2654010 A CA 2654010A CA 2654010 A1 CA2654010 A1 CA 2654010A1
- Authority
- CA
- Canada
- Prior art keywords
- nucleic acid
- seq
- derivative
- nucleotides
- hybridizing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 562
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 556
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 556
- 244000005700 microbiome Species 0.000 title abstract description 78
- 238000001514 detection method Methods 0.000 title abstract description 42
- 230000000813 microbial effect Effects 0.000 title abstract description 33
- 238000004458 analytical method Methods 0.000 title abstract description 7
- 125000003729 nucleotide group Chemical group 0.000 claims description 225
- 239000002773 nucleotide Substances 0.000 claims description 224
- 241000700605 Viruses Species 0.000 claims description 53
- 241000191940 Staphylococcus Species 0.000 claims description 40
- 241000282414 Homo sapiens Species 0.000 claims description 31
- 208000006454 hepatitis Diseases 0.000 claims description 15
- 231100000283 hepatitis Toxicity 0.000 claims description 15
- 241000150489 Andes orthohantavirus Species 0.000 claims description 14
- 241000150452 Orthohantavirus Species 0.000 claims description 14
- 241000224016 Plasmodium Species 0.000 claims description 14
- 241000713124 Rift Valley fever virus Species 0.000 claims description 13
- 241000150288 Sin Nombre orthohantavirus Species 0.000 claims description 13
- 241000960387 Torque teno virus Species 0.000 claims description 13
- 241000991587 Enterovirus C Species 0.000 claims description 11
- 241000190708 Guanarito mammarenavirus Species 0.000 claims description 10
- 241000712890 Junin mammarenavirus Species 0.000 claims description 10
- 241000712902 Lassa mammarenavirus Species 0.000 claims description 10
- 241000712898 Machupo mammarenavirus Species 0.000 claims description 10
- 241000192617 Sabia mammarenavirus Species 0.000 claims description 10
- 244000309467 Human Coronavirus Species 0.000 claims description 8
- 241000588653 Neisseria Species 0.000 claims description 8
- 241000193403 Clostridium Species 0.000 claims description 7
- 241000589291 Acinetobacter Species 0.000 claims description 6
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 6
- 241001479210 Human astrovirus Species 0.000 claims description 6
- 241000046923 Human bocavirus Species 0.000 claims description 6
- 241000725303 Human immunodeficiency virus Species 0.000 claims description 6
- 241000342334 Human metapneumovirus Species 0.000 claims description 6
- 241000710842 Japanese encephalitis virus Species 0.000 claims description 6
- 241001115401 Marburgvirus Species 0.000 claims description 6
- 241000712079 Measles morbillivirus Species 0.000 claims description 6
- 241000711386 Mumps virus Species 0.000 claims description 6
- 241000526636 Nipah henipavirus Species 0.000 claims description 6
- 241001263478 Norovirus Species 0.000 claims description 6
- 241000714209 Norwalk virus Species 0.000 claims description 6
- 241000873939 Parechovirus A Species 0.000 claims description 6
- 241000711798 Rabies lyssavirus Species 0.000 claims description 6
- 241000710942 Ross River virus Species 0.000 claims description 6
- 241000315672 SARS coronavirus Species 0.000 claims description 6
- 241000589886 Treponema Species 0.000 claims description 6
- 241000710886 West Nile virus Species 0.000 claims description 6
- 241000710772 Yellow fever virus Species 0.000 claims description 6
- 241000710929 Alphavirus Species 0.000 claims description 5
- 206010066919 Epidemic polyarthritis Diseases 0.000 claims description 5
- 241001207270 Human enterovirus Species 0.000 claims description 5
- 241000711920 Human orthopneumovirus Species 0.000 claims description 5
- 241000829111 Human polyomavirus 1 Species 0.000 claims description 5
- 241000701460 JC polyomavirus Species 0.000 claims description 5
- 241000700627 Monkeypox virus Species 0.000 claims description 5
- 229940051021 yellow-fever virus Drugs 0.000 claims description 5
- 241000607142 Salmonella Species 0.000 claims description 4
- 241000588807 Bordetella Species 0.000 claims description 3
- 241000589968 Borrelia Species 0.000 claims description 3
- 241000589876 Campylobacter Species 0.000 claims description 3
- 241001337994 Cryptococcus <scale insect> Species 0.000 claims description 3
- 241001115402 Ebolavirus Species 0.000 claims description 3
- 241000605314 Ehrlichia Species 0.000 claims description 3
- 241000588724 Escherichia coli Species 0.000 claims description 3
- 241000589601 Francisella Species 0.000 claims description 3
- 241000589989 Helicobacter Species 0.000 claims description 3
- 241000598171 Human adenovirus sp. Species 0.000 claims description 3
- 241000430519 Human rhinovirus sp. Species 0.000 claims description 3
- 241000186781 Listeria Species 0.000 claims description 3
- 208000016604 Lyme disease Diseases 0.000 claims description 3
- 241000235527 Rhizopus Species 0.000 claims description 3
- 241000702670 Rotavirus Species 0.000 claims description 3
- 241000194017 Streptococcus Species 0.000 claims description 3
- 241000607734 Yersinia <bacteria> Species 0.000 claims description 3
- 241000712461 unidentified influenza virus Species 0.000 claims description 3
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 claims description 2
- 241000606125 Bacteroides Species 0.000 claims description 2
- 241000606660 Bartonella Species 0.000 claims description 2
- 241000589562 Brucella Species 0.000 claims description 2
- 241001137864 Camelpox virus Species 0.000 claims description 2
- 241000606161 Chlamydia Species 0.000 claims description 2
- 241000204955 Colorado tick fever virus Species 0.000 claims description 2
- 241000700626 Cowpox virus Species 0.000 claims description 2
- 241001445332 Coxiella <snail> Species 0.000 claims description 2
- 241000725619 Dengue virus Species 0.000 claims description 2
- 241000710945 Eastern equine encephalitis virus Species 0.000 claims description 2
- 241000194033 Enterococcus Species 0.000 claims description 2
- 241000606790 Haemophilus Species 0.000 claims description 2
- 241000711549 Hepacivirus C Species 0.000 claims description 2
- 241000589248 Legionella Species 0.000 claims description 2
- 208000007764 Legionnaires' Disease Diseases 0.000 claims description 2
- 241000589902 Leptospira Species 0.000 claims description 2
- 241000710908 Murray Valley encephalitis virus Species 0.000 claims description 2
- 241000187488 Mycobacterium sp. Species 0.000 claims description 2
- 241000204031 Mycoplasma Species 0.000 claims description 2
- 241001537205 Paracoccidioides Species 0.000 claims description 2
- 241000125945 Protoparvovirus Species 0.000 claims description 2
- 241000589774 Pseudomonas sp. Species 0.000 claims description 2
- 241000606701 Rickettsia Species 0.000 claims description 2
- 241000607758 Shigella sp. Species 0.000 claims description 2
- 241000187747 Streptomyces Species 0.000 claims description 2
- 241000726423 Variola major virus Species 0.000 claims description 2
- 241000519618 Variola minor virus Species 0.000 claims description 2
- 241000710959 Venezuelan equine encephalitis virus Species 0.000 claims description 2
- 241000607598 Vibrio Species 0.000 claims description 2
- 241000710951 Western equine encephalitis virus Species 0.000 claims description 2
- 241001529453 unidentified herpesvirus Species 0.000 claims description 2
- 241000605909 Fusobacterium Species 0.000 claims 1
- 108020004414 DNA Proteins 0.000 abstract description 86
- 238000000034 method Methods 0.000 abstract description 56
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical class NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 abstract description 48
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 abstract description 34
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 abstract description 20
- 229940035893 uracil Drugs 0.000 abstract description 17
- 102000053602 DNA Human genes 0.000 abstract description 10
- 229940113082 thymine Drugs 0.000 abstract description 9
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 7
- 230000000295 complement effect Effects 0.000 abstract description 3
- 230000008569 process Effects 0.000 abstract description 3
- 230000004075 alteration Effects 0.000 abstract description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 abstract 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 abstract 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 abstract 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 abstract 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 abstract 1
- 229960005305 adenosine Drugs 0.000 abstract 1
- 229940029575 guanosine Drugs 0.000 abstract 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 123
- 208000005176 Hepatitis C Diseases 0.000 description 88
- 239000000523 sample Substances 0.000 description 58
- 230000003321 amplification Effects 0.000 description 49
- 238000003199 nucleic acid amplification method Methods 0.000 description 49
- 208000009802 Colorado tick fever Diseases 0.000 description 46
- 241000223960 Plasmodium falciparum Species 0.000 description 46
- 241001506005 Rotavirus C Species 0.000 description 44
- 241001137860 Rotavirus A Species 0.000 description 39
- 239000000147 enterotoxin Substances 0.000 description 39
- 241001137861 Rotavirus B Species 0.000 description 32
- 101710146739 Enterotoxin Proteins 0.000 description 31
- 231100000655 enterotoxin Toxicity 0.000 description 31
- 241000193155 Clostridium botulinum Species 0.000 description 28
- 229940104302 cytosine Drugs 0.000 description 22
- 238000009396 hybridization Methods 0.000 description 22
- 238000006243 chemical reaction Methods 0.000 description 19
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 17
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 16
- 108030001720 Bontoxilysin Proteins 0.000 description 16
- 229940053031 botulinum toxin Drugs 0.000 description 16
- 101710144128 Non-structural protein 2 Proteins 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 101710144127 Non-structural protein 1 Proteins 0.000 description 13
- 108091093037 Peptide nucleic acid Proteins 0.000 description 13
- 238000003752 polymerase chain reaction Methods 0.000 description 13
- 102100028253 Breast cancer anti-estrogen resistance protein 3 Human genes 0.000 description 12
- 108020004635 Complementary DNA Proteins 0.000 description 12
- 201000011001 Ebola Hemorrhagic Fever Diseases 0.000 description 12
- 241000150562 Hantaan orthohantavirus Species 0.000 description 12
- 101710144111 Non-structural protein 3 Proteins 0.000 description 12
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 12
- 102100021798 SH2 domain-containing protein 3C Human genes 0.000 description 12
- 210000003470 mitochondria Anatomy 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 101710138767 Non-structural glycoprotein 4 Proteins 0.000 description 11
- 108091034117 Oligonucleotide Proteins 0.000 description 11
- 102100031056 Serine protease 57 Human genes 0.000 description 11
- 101710197596 Serine protease 57 Proteins 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- 229940088598 enzyme Drugs 0.000 description 11
- 241000894007 species Species 0.000 description 11
- 102100031776 SH2 domain-containing protein 3A Human genes 0.000 description 10
- 208000001203 Smallpox Diseases 0.000 description 10
- 238000010804 cDNA synthesis Methods 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 239000002299 complementary DNA Substances 0.000 description 10
- 238000009830 intercalation Methods 0.000 description 10
- 108091008146 restriction endonucleases Proteins 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 238000003556 assay Methods 0.000 description 9
- 241001148106 Brucella melitensis Species 0.000 description 8
- -1 altritol nucleic acid Chemical class 0.000 description 8
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 7
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 7
- 241000589929 Leptospira interrogans Species 0.000 description 7
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 7
- 229940038698 brucella melitensis Drugs 0.000 description 7
- 238000006073 displacement reaction Methods 0.000 description 7
- 230000002255 enzymatic effect Effects 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 241000606153 Chlamydia trachomatis Species 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 230000004544 DNA amplification Effects 0.000 description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
- 241000606768 Haemophilus influenzae Species 0.000 description 6
- 201000009906 Meningitis Diseases 0.000 description 6
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000007983 Tris buffer Substances 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 229940038705 chlamydia trachomatis Drugs 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 239000002853 nucleic acid probe Substances 0.000 description 6
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 6
- 241000186216 Corynebacterium Species 0.000 description 5
- 238000007400 DNA extraction Methods 0.000 description 5
- 241000191967 Staphylococcus aureus Species 0.000 description 5
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000011324 bead Substances 0.000 description 5
- 206010014599 encephalitis Diseases 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 229940047650 haemophilus influenzae Drugs 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 239000008188 pellet Substances 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 201000006266 variola major Diseases 0.000 description 5
- 201000000627 variola minor Diseases 0.000 description 5
- 208000014016 variola minor infection Diseases 0.000 description 5
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 4
- 229930024421 Adenine Natural products 0.000 description 4
- XFTWUNOVBCHBJR-UHFFFAOYSA-N Aspergillomarasmine A Chemical compound OC(=O)C(N)CNC(C(O)=O)CNC(C(O)=O)CC(O)=O XFTWUNOVBCHBJR-UHFFFAOYSA-N 0.000 description 4
- 241000228245 Aspergillus niger Species 0.000 description 4
- 241000193738 Bacillus anthracis Species 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 description 4
- 241000710946 Barmah Forest virus Species 0.000 description 4
- 241001518086 Bartonella henselae Species 0.000 description 4
- 241000606108 Bartonella quintana Species 0.000 description 4
- 241000589969 Borreliella burgdorferi Species 0.000 description 4
- 101100240528 Caenorhabditis elegans nhr-23 gene Proteins 0.000 description 4
- 241000282836 Camelus dromedarius Species 0.000 description 4
- 241000222122 Candida albicans Species 0.000 description 4
- 241000436315 Candida metapsilosis Species 0.000 description 4
- 241000436311 Candida orthopsilosis Species 0.000 description 4
- 241000222173 Candida parapsilosis Species 0.000 description 4
- 241001660259 Cereus <cactus> Species 0.000 description 4
- 241000193468 Clostridium perfringens Species 0.000 description 4
- 241000193449 Clostridium tetani Species 0.000 description 4
- 102100038284 Cytospin-B Human genes 0.000 description 4
- 241000710827 Dengue virus 1 Species 0.000 description 4
- 241000710815 Dengue virus 2 Species 0.000 description 4
- 241000710872 Dengue virus 3 Species 0.000 description 4
- 241000710844 Dengue virus 4 Species 0.000 description 4
- 206010014587 Encephalitis eastern equine Diseases 0.000 description 4
- 206010014611 Encephalitis venezuelan equine Diseases 0.000 description 4
- 206010014614 Encephalitis western equine Diseases 0.000 description 4
- 241000988556 Enterovirus B Species 0.000 description 4
- 241000991586 Enterovirus D Species 0.000 description 4
- 241000605986 Fusobacterium nucleatum Species 0.000 description 4
- 241000893570 Hendra henipavirus Species 0.000 description 4
- 208000005331 Hepatitis D Diseases 0.000 description 4
- 241000701074 Human alphaherpesvirus 2 Species 0.000 description 4
- 241000701085 Human alphaherpesvirus 3 Species 0.000 description 4
- 241000701024 Human betaherpesvirus 5 Species 0.000 description 4
- 241001455657 Human betaherpesvirus 6A Species 0.000 description 4
- 241001455656 Human betaherpesvirus 6B Species 0.000 description 4
- 241000701041 Human betaherpesvirus 7 Species 0.000 description 4
- 241000711467 Human coronavirus 229E Species 0.000 description 4
- 241000482741 Human coronavirus NL63 Species 0.000 description 4
- 241000701044 Human gammaherpesvirus 4 Species 0.000 description 4
- 241001502974 Human gammaherpesvirus 8 Species 0.000 description 4
- 241000620571 Human mastadenovirus A Species 0.000 description 4
- 241001545456 Human mastadenovirus B Species 0.000 description 4
- 241000886679 Human mastadenovirus D Species 0.000 description 4
- 241000886703 Human mastadenovirus E Species 0.000 description 4
- 241000886705 Human mastadenovirus F Species 0.000 description 4
- 241000702617 Human parvovirus B19 Species 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 201000005805 Murray valley encephalitis Diseases 0.000 description 4
- 241000186367 Mycobacterium avium Species 0.000 description 4
- 241000186362 Mycobacterium leprae Species 0.000 description 4
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 4
- 241001503673 Nocardia farcinica Species 0.000 description 4
- 101710144121 Non-structural protein 5 Proteins 0.000 description 4
- 238000012408 PCR amplification Methods 0.000 description 4
- 241000526686 Paracoccidioides brasiliensis Species 0.000 description 4
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 241001325464 Rhinovirus A Species 0.000 description 4
- 241001325459 Rhinovirus B Species 0.000 description 4
- 241000606699 Rickettsia conorii Species 0.000 description 4
- 241000606697 Rickettsia prowazekii Species 0.000 description 4
- 241000606726 Rickettsia typhi Species 0.000 description 4
- 101900097299 Rotavirus A Non-structural protein 5 Proteins 0.000 description 4
- 108700042108 Rotavirus B gene 11 Proteins 0.000 description 4
- 241001138501 Salmonella enterica Species 0.000 description 4
- 241000607720 Serratia Species 0.000 description 4
- 241000191963 Staphylococcus epidermidis Species 0.000 description 4
- 241000191984 Staphylococcus haemolyticus Species 0.000 description 4
- 241000193985 Streptococcus agalactiae Species 0.000 description 4
- 241000194019 Streptococcus mutans Species 0.000 description 4
- 241000193998 Streptococcus pneumoniae Species 0.000 description 4
- 101710173681 Sulfate adenylyltransferase subunit 2 2 Proteins 0.000 description 4
- 108010057266 Type A Botulinum Toxins Proteins 0.000 description 4
- 241000607626 Vibrio cholerae Species 0.000 description 4
- 241000192286 [Candida] stellata Species 0.000 description 4
- 241000606834 [Haemophilus] ducreyi Species 0.000 description 4
- 229960000643 adenine Drugs 0.000 description 4
- 229940092523 bartonella quintana Drugs 0.000 description 4
- 108010069023 botulinum toxin type E Proteins 0.000 description 4
- 229940095731 candida albicans Drugs 0.000 description 4
- 229940055022 candida parapsilosis Drugs 0.000 description 4
- 239000000306 component Substances 0.000 description 4
- 201000003740 cowpox Diseases 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 208000005252 hepatitis A Diseases 0.000 description 4
- 208000002672 hepatitis B Diseases 0.000 description 4
- 201000010284 hepatitis E Diseases 0.000 description 4
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 4
- 229940037649 staphylococcus haemolyticus Drugs 0.000 description 4
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 230000003612 virological effect Effects 0.000 description 4
- 108020004465 16S ribosomal RNA Proteins 0.000 description 3
- 241000228232 Aspergillus tubingensis Species 0.000 description 3
- 241000588832 Bordetella pertussis Species 0.000 description 3
- 241000606678 Coxiella burnetii Species 0.000 description 3
- 201000007336 Cryptococcosis Diseases 0.000 description 3
- 241000221204 Cryptococcus neoformans Species 0.000 description 3
- 102000000311 Cytosine Deaminase Human genes 0.000 description 3
- 108010080611 Cytosine Deaminase Proteins 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 208000006825 Eastern Equine Encephalomyelitis Diseases 0.000 description 3
- 201000005804 Eastern equine encephalitis Diseases 0.000 description 3
- 241000605310 Ehrlichia chaffeensis Species 0.000 description 3
- 102100031780 Endonuclease Human genes 0.000 description 3
- 108010067770 Endopeptidase K Proteins 0.000 description 3
- 241000283073 Equus caballus Species 0.000 description 3
- 241000589602 Francisella tularensis Species 0.000 description 3
- 241000531123 GB virus C Species 0.000 description 3
- 241000590002 Helicobacter pylori Species 0.000 description 3
- 241000620147 Human mastadenovirus C Species 0.000 description 3
- 241000589242 Legionella pneumophila Species 0.000 description 3
- 241000186779 Listeria monocytogenes Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000588652 Neisseria gonorrhoeae Species 0.000 description 3
- 240000005384 Rhizopus oryzae Species 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 241000607766 Shigella boydii Species 0.000 description 3
- 241000607764 Shigella dysenteriae Species 0.000 description 3
- 241000607762 Shigella flexneri Species 0.000 description 3
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical group [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 3
- 241000193996 Streptococcus pyogenes Species 0.000 description 3
- 241000187432 Streptomyces coelicolor Species 0.000 description 3
- 101710140501 Sulfate adenylyltransferase subunit 2 1 Proteins 0.000 description 3
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 3
- 229920004890 Triton X-100 Polymers 0.000 description 3
- 239000013504 Triton X-100 Substances 0.000 description 3
- 208000002687 Venezuelan Equine Encephalomyelitis Diseases 0.000 description 3
- 201000009145 Venezuelan equine encephalitis Diseases 0.000 description 3
- 208000005466 Western Equine Encephalomyelitis Diseases 0.000 description 3
- 201000005806 Western equine encephalitis Diseases 0.000 description 3
- 241000607479 Yersinia pestis Species 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 238000003491 array Methods 0.000 description 3
- 229940065181 bacillus anthracis Drugs 0.000 description 3
- 229940092524 bartonella henselae Drugs 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 239000003638 chemical reducing agent Substances 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 229940118764 francisella tularensis Drugs 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000000138 intercalating agent Substances 0.000 description 3
- 125000005647 linker group Chemical group 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 150000008300 phosphoramidites Chemical class 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 229940046939 rickettsia prowazekii Drugs 0.000 description 3
- 229940007046 shigella dysenteriae Drugs 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 229940118696 vibrio cholerae Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 244000153158 Ammi visnaga Species 0.000 description 2
- 235000010585 Ammi visnaga Nutrition 0.000 description 2
- 241000589875 Campylobacter jejuni Species 0.000 description 2
- 241001647372 Chlamydia pneumoniae Species 0.000 description 2
- 241001517041 Corynebacterium jeikeium Species 0.000 description 2
- 238000000018 DNA microarray Methods 0.000 description 2
- 102000007260 Deoxyribonuclease I Human genes 0.000 description 2
- 108010008532 Deoxyribonuclease I Proteins 0.000 description 2
- 241000194032 Enterococcus faecalis Species 0.000 description 2
- 241000988559 Enterovirus A Species 0.000 description 2
- 101000867232 Escherichia coli Heat-stable enterotoxin II Proteins 0.000 description 2
- 241000192125 Firmicutes Species 0.000 description 2
- 206010016952 Food poisoning Diseases 0.000 description 2
- 208000019331 Foodborne disease Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 241000700588 Human alphaherpesvirus 1 Species 0.000 description 2
- 241001109669 Human coronavirus HKU1 Species 0.000 description 2
- 206010020429 Human ehrlichiosis Diseases 0.000 description 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 108060004795 Methyltransferase Proteins 0.000 description 2
- 241000202934 Mycoplasma pneumoniae Species 0.000 description 2
- 241000588650 Neisseria meningitidis Species 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 235000013752 Rhizopus oryzae Nutrition 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- 238000002105 Southern blotting Methods 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical group OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 2
- 241000203826 Tropheryma whipplei Species 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 238000009640 blood culture Methods 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229940015062 campylobacter jejuni Drugs 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000009615 deamination Effects 0.000 description 2
- 238000006481 deamination reaction Methods 0.000 description 2
- NAGJZTKCGNOGPW-UHFFFAOYSA-N dithiophosphoric acid Chemical class OP(O)(S)=S NAGJZTKCGNOGPW-UHFFFAOYSA-N 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 229940037467 helicobacter pylori Drugs 0.000 description 2
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 238000011901 isothermal amplification Methods 0.000 description 2
- 229940115932 legionella pneumophila Drugs 0.000 description 2
- 238000007834 ligase chain reaction Methods 0.000 description 2
- LPHFLPKXBKBHRW-UHFFFAOYSA-L magnesium;hydrogen sulfite Chemical compound [Mg+2].OS([O-])=O.OS([O-])=O LPHFLPKXBKBHRW-UHFFFAOYSA-L 0.000 description 2
- ACIQAOGCMGBUKY-UHFFFAOYSA-N methyl 1H-phosphole-2-carboxylate Chemical class P1C(=CC=C1)C(=O)OC ACIQAOGCMGBUKY-UHFFFAOYSA-N 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 238000002493 microarray Methods 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 125000000371 nucleobase group Chemical group 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 125000004437 phosphorous atom Chemical group 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- JRPHGDYSKGJTKZ-UHFFFAOYSA-N selenophosphoric acid Chemical class OP(O)([SeH])=O JRPHGDYSKGJTKZ-UHFFFAOYSA-N 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
- 229940001584 sodium metabisulfite Drugs 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- YOVIGIMYOOIFQP-UHFFFAOYSA-N 1h-pyrimidine-2,4-dione;sulfurous acid Chemical compound OS(O)=O.O=C1C=CNC(=O)N1 YOVIGIMYOOIFQP-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical group OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 108020000992 Ancient DNA Proteins 0.000 description 1
- 241000837181 Andina Species 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 241001135755 Betaproteobacteria Species 0.000 description 1
- 238000009631 Broth culture Methods 0.000 description 1
- KSSJBGNOJJETTC-UHFFFAOYSA-N COC1=C(C=CC=C1)N(C1=CC=2C3(C4=CC(=CC=C4C=2C=C1)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC(=CC=C1C=1C=CC(=CC=13)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC=C(C=C1)OC Chemical compound COC1=C(C=CC=C1)N(C1=CC=2C3(C4=CC(=CC=C4C=2C=C1)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC(=CC=C1C=1C=CC(=CC=13)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)N(C1=CC=C(C=C1)OC)C1=C(C=CC=C1)OC)C1=CC=C(C=C1)OC KSSJBGNOJJETTC-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 241000884368 Enterococcus faecalis T2 Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 108091092584 GDNA Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000341655 Human papillomavirus type 16 Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 108090000988 Lysostaphin Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 1
- 241000588656 Neisseriaceae Species 0.000 description 1
- 241001212279 Neisseriales Species 0.000 description 1
- 101710147059 Nicking endonuclease Proteins 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000192142 Proteobacteria Species 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 108020001027 Ribosomal DNA Chemical group 0.000 description 1
- 208000000705 Rift Valley Fever Diseases 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 241000589973 Spirochaeta Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- 241000203807 Tropheryma Species 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 241000726445 Viroids Species 0.000 description 1
- 208000004143 Waterhouse-Friderichsen Syndrome Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 208000014117 bile duct papillary neoplasm Diseases 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M bisulphate group Chemical group S([O-])(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 210000002459 blastocyst Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 150000005829 chemical entities Chemical class 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 239000007330 chocolate agar Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008358 core component Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 1
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 108010093801 endodeoxyribonuclease BstNBI Proteins 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000002875 fluorescence polarization Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- BTIJJDXEELBZFS-UHFFFAOYSA-K hemin Chemical compound [Cl-].[Fe+3].[N-]1C(C=C2C(=C(C)C(C=C3C(=C(C)C(=C4)[N-]3)C=C)=N2)C=C)=C(C)C(CCC(O)=O)=C1C=C1C(CCC(O)=O)=C(C)C4=N1 BTIJJDXEELBZFS-UHFFFAOYSA-K 0.000 description 1
- 208000010710 hepatitis C virus infection Diseases 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-N hydrogen thiocyanate Natural products SC#N ZMZDMBWJUHKJPS-UHFFFAOYSA-N 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 229950006238 nadide Drugs 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 150000004713 phosphodiesters Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 239000002157 polynucleotide Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000001177 retroviral effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000007423 screening assay Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000012128 staining reagent Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 210000004722 stifle Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 239000001974 tryptic soy broth Substances 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/AU2006/000755 WO2007140506A1 (en) | 2006-06-02 | 2006-06-02 | Modified microbial nucleic acid for use in detection and analysis of microorganisms |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2654010A1 true CA2654010A1 (en) | 2007-12-13 |
Family
ID=38800944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002654010A Abandoned CA2654010A1 (en) | 2006-06-02 | 2006-06-02 | Modified microbial nucleic acid for use in detection and analysis of microorganisms |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP2021497A1 (ja) |
| JP (1) | JP2009538603A (ja) |
| CN (1) | CN101522908A (ja) |
| AU (1) | AU2006344331A1 (ja) |
| CA (1) | CA2654010A1 (ja) |
| WO (1) | WO2007140506A1 (ja) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101680033A (zh) * | 2007-03-16 | 2010-03-24 | 人类遗传标记控股有限公司 | 基因表达的测定方法 |
| FR2940805B1 (fr) | 2009-01-05 | 2015-10-16 | Biomerieux Sa | Procede d'amplification et/ou de detection d'acides nucleiques, kits et utilisations de ce procede |
| WO2010121308A1 (en) * | 2009-04-23 | 2010-10-28 | Human Genetic Signatures Pty Ltd | Detection of hepatitis c virus |
| US8628947B2 (en) | 2010-08-30 | 2014-01-14 | Intervet Inc. | Potomac horse fever isolates |
| ES2613743T3 (es) * | 2011-09-07 | 2017-05-25 | Human Genetic Signatures Pty Ltd | Ensayo de detección molecular |
| WO2013082500A2 (en) | 2011-12-02 | 2013-06-06 | Rhode Island Hospital | Vaccine for falciparum malaria |
| CN103173536B (zh) * | 2012-12-21 | 2014-10-08 | 山东出入境检验检疫局检验检疫技术中心 | 单核细胞增生李斯特氏菌的切刻内切酶核酸恒温扩增快速检测试剂盒 |
| US9775894B2 (en) | 2013-07-09 | 2017-10-03 | University Of Washington Through Its Center For Commercialization | Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling |
| CN106103470B (zh) * | 2013-12-30 | 2020-10-27 | 丹尼斯科美国公司 | 增强的蛋白质表达 |
| US10342861B2 (en) | 2014-05-27 | 2019-07-09 | University Of Rochester | Arenavirus vaccine |
| CN108977457B (zh) * | 2018-08-31 | 2021-04-02 | 长江大学 | 一种黄鳝抗菌肽的制备方法 |
| EP3902917A4 (en) * | 2018-12-27 | 2022-11-30 | bioAffinity Technologies, Inc. | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER |
| CN110157710B (zh) * | 2019-07-11 | 2022-12-27 | 贵州大学 | 花烟草NaD1基因启动子及其用途 |
| CN110343703B (zh) * | 2019-07-17 | 2022-12-27 | 中国科学院海洋研究所 | 三疣梭子蟹C型凝集素PtCLec1基因及其编码蛋白和应用 |
| CN111019943A (zh) * | 2019-12-03 | 2020-04-17 | 西北农林科技大学 | 一种苹果果糖激酶基因的启动子序列、缺失突变体及应用 |
| CN112662670B (zh) * | 2020-12-25 | 2024-04-02 | 河南省农业科学院 | 花生脂酰-酰基载体蛋白硫酯酶AhFATB2基因启动子及其制备方法和应用 |
| WO2022175356A1 (en) * | 2021-02-17 | 2022-08-25 | Viralga Sas | Control of green algae blooms |
| EP4453245A2 (en) * | 2021-12-23 | 2024-10-30 | Mammoth Biosciences, Inc. | Programmable nuclease-based assay improvements |
| AU2023254106A1 (en) * | 2022-04-14 | 2024-10-24 | Shift Pharmaceuticals Holding Inc. | Polynucleotide treatments for charcot-marie-tooth disease |
| WO2024119461A1 (en) * | 2022-12-09 | 2024-06-13 | Westlake University | Compositions and methods for detecting target cleavage sites of crispr/cas nucleases and dna translocation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10236406C1 (de) * | 2002-08-02 | 2003-12-24 | Epigenomics Ag | Verfahren zur Amplifikation von Nukleinsäuren mit geringer Komplexität |
| DK1828411T3 (da) * | 2004-12-03 | 2013-02-18 | Human Genetic Signatures Pty | Fremgangsmåde til forenkling af mikrobielle nukleinsyrer ved kemisk modifikation af cytosiner |
-
2006
- 2006-06-02 CN CN200680055508A patent/CN101522908A/zh active Pending
- 2006-06-02 JP JP2009512366A patent/JP2009538603A/ja active Pending
- 2006-06-02 CA CA002654010A patent/CA2654010A1/en not_active Abandoned
- 2006-06-02 AU AU2006344331A patent/AU2006344331A1/en not_active Abandoned
- 2006-06-02 WO PCT/AU2006/000755 patent/WO2007140506A1/en active Application Filing
- 2006-06-02 EP EP06741172A patent/EP2021497A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007140506A1 (en) | 2007-12-13 |
| JP2009538603A (ja) | 2009-11-12 |
| CN101522908A (zh) | 2009-09-02 |
| EP2021497A1 (en) | 2009-02-11 |
| WO2007140506A8 (en) | 2010-04-15 |
| AU2006344331A1 (en) | 2007-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2654010A1 (en) | Modified microbial nucleic acid for use in detection and analysis of microorganisms | |
| CA2589668C (en) | Methods for simplifying microbial nucleic acids by chemical modification of cytosines | |
| US9315863B2 (en) | Sequence-specific methods for homogeneous, real-time detection of lamp products | |
| JP4999460B2 (ja) | 核酸のプライマーに基づく増幅のための方法及びキット | |
| JP6739339B2 (ja) | カバーされた配列変換ｄｎａおよび検出方法 | |
| US20080050738A1 (en) | Detection of target nucleic acid | |
| AU3948795A (en) | Compositions and methods for the detection of chlamydia trachomatis | |
| WO2010080691A1 (en) | Cross priming amplification of target nucleic acids | |
| JPH09511654A (ja) | マイコプラズマ・ニューモニエ核酸を標的とする核酸ハイブリダイゼーションアッセイプローブ | |
| EP2396422B1 (en) | Assay for trichomonas vaginalis by amplification and detection of trichomonas vaginalis ap65-1 gene | |
| JP2001103986A (ja) | 鳥型結核菌複合種の増幅および検出 | |
| EP2829616B1 (en) | Composition and methods for detecting nucleic acid from mollicutes | |
| JPH10511271A (ja) | Ｃｏｃｃｉｄｉｏｉｄｅｓ ｉｍｍｉｔｉｓの検出のための増幅プライマーと核酸プローブ | |
| JPWO2009044773A1 (ja) | レジオネラ属菌ｒＲＮＡ増幅用プライマー、検出方法および検出キット | |
| EP1176215A2 (en) | Amplification and detection of mycoplasma pneumoniae | |
| JP2003219878A (ja) | レジオネラ属菌検出のためのプライマーおよびそれを用いた検出法 | |
| AU2005312354B2 (en) | Methods for simplifying microbial nucleic acids by chemical modification of cytosines | |
| JP2003516765A (ja) | 鳥型結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍａｖｉｕｍ）複合体種の検出のための方法および組成物 | |
| CA2443776A1 (en) | Amplification and detection of mycoplasma pneumoniae | |
| NZ564991A (en) | Multiplexed polymerase chain reaction for genetic sequence analysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |